340 related articles for article (PubMed ID: 33972683)
1. N6-methyladenosine demethyltransferase FTO-mediated autophagy in malignant development of oral squamous cell carcinoma.
Wang F; Liao Y; Zhang M; Zhu Y; Wang W; Cai H; Liang J; Song F; Hou C; Huang S; Zhang Y; Wang C; Hou J
Oncogene; 2021 Jun; 40(22):3885-3898. PubMed ID: 33972683
[TBL] [Abstract][Full Text] [Related]
2. m
Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y
Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060
[TBL] [Abstract][Full Text] [Related]
3. FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability.
Xu Y; Zhou J; Li L; Yang W; Zhang Z; Zhang K; Ma K; Xie H; Zhang Z; Cai L; Gong Y; Gong K
Int J Biol Sci; 2022; 18(15):5943-5962. PubMed ID: 36263177
[TBL] [Abstract][Full Text] [Related]
4. N6-Methyladenosine Methyltransferase METTL14-Mediated Autophagy in Malignant Development of Oral Squamous Cell Carcinoma.
Wang F; Zhu Y; Cai H; Liang J; Wang W; Liao Y; Zhang Y; Wang C; Hou J
Front Oncol; 2021; 11():738406. PubMed ID: 34900689
[TBL] [Abstract][Full Text] [Related]
5. RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m
Tan Z; Shi S; Xu J; Liu X; Lei Y; Zhang B; Hua J; Meng Q; Wang W; Yu X; Liang C
Oncogene; 2022 May; 41(20):2860-2872. PubMed ID: 35422475
[TBL] [Abstract][Full Text] [Related]
6. FTO demethylates YAP mRNA promoting oral squamous cell carcinoma tumorigenesis.
Li DQ; Huang CC; Zhang G; Zhou LL
Neoplasma; 2022 Jan; 69(1):71-79. PubMed ID: 34779644
[TBL] [Abstract][Full Text] [Related]
7. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
8. The m
Romanowska K; Rawłuszko-Wieczorek AA; Marczak Ł; Kosińska A; Suchorska WM; Golusiński W
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207099
[TBL] [Abstract][Full Text] [Related]
9. FTO-Dependent
Huang H; Wang Y; Kandpal M; Zhao G; Cardenas H; Ji Y; Chaparala A; Tanner EJ; Chen J; Davuluri RV; Matei D
Cancer Res; 2020 Aug; 80(16):3200-3214. PubMed ID: 32606006
[No Abstract] [Full Text] [Related]
10. Fat mass and obesity-associated protein regulates tumorigenesis of arecoline-promoted human oral carcinoma.
Li X; Xie X; Gu Y; Zhang J; Song J; Cheng X; Gao Y; Ai Y
Cancer Med; 2021 Sep; 10(18):6402-6415. PubMed ID: 34378866
[TBL] [Abstract][Full Text] [Related]
11. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
[TBL] [Abstract][Full Text] [Related]
12. METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner.
Liang J; Cai H; Hou C; Song F; Jiang Y; Wang Z; Qiu D; Zhu Y; Wang F; Yu D; Hou J
Clin Sci (Lond); 2023 Sep; 137(17):1373-1389. PubMed ID: 37615536
[TBL] [Abstract][Full Text] [Related]
13. Cobalt induces neurodegeneration through FTO-triggered autophagy impairment by targeting TSC1 in an m
Tang J; Zheng F; Liu X; Li Y; Guo Z; Lin X; Zhou J; Zhang Y; Yu G; Hu H; Shao W; Wu S; Li H
J Hazard Mater; 2023 Jul; 453():131354. PubMed ID: 37054644
[TBL] [Abstract][Full Text] [Related]
14. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
[TBL] [Abstract][Full Text] [Related]
15. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
[TBL] [Abstract][Full Text] [Related]
16. FTO facilitates cancer metastasis by modifying the m
Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739
[TBL] [Abstract][Full Text] [Related]
17. Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m
Sun K; Du Y; Hou Y; Zhao M; Li J; Du Y; Zhang L; Chen C; Yang H; Yan F; Su R
Theranostics; 2021; 11(12):5831-5846. PubMed ID: 33897884
[No Abstract] [Full Text] [Related]
18. FTO elicits tumor neovascularization in cancer-associated fibroblasts through eliminating m
Liao Q; Shi H; Yang J; Ge S; Jia R; Song X; Chai P; Jia R
Cancer Lett; 2024 Jun; 592():216911. PubMed ID: 38685450
[TBL] [Abstract][Full Text] [Related]
19. FTO regulates adipogenesis by controlling cell cycle progression via m
Wu R; Liu Y; Yao Y; Zhao Y; Bi Z; Jiang Q; Liu Q; Cai M; Wang F; Wang Y; Wang X
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1323-1330. PubMed ID: 30305247
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
Song W; Yang K; Luo J; Gao Z; Gao Y
Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
